GILD vs ABBV
Gilead Sciences vs AbbVie — AI-powered side-by-side comparison
| Metric | GILD | ABBV |
|---|---|---|
| AI Score | 65 | 56 |
| Price | $133.97 | $248.48 |
| P/E Ratio | 18.11× | 123.77× |
| ROE | 42.2% | 95.6% |
| Revenue Growth YoY | 3.5% | 9.5% |
| Gross Margin | 79.3% | 72.0% |
| Debt / Equity | 1.10× | 20.19× |
| Dividend Yield | 2.4% | 2.7% |
| RSI (14) | 72.4 | 63.7 |
| Beta | 0.3411 | 0.2721 |
| Expected Upside | +15.8% | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
GILD Full Analysis
ABBV Full Analysis